QT Imaging Holdings, Inc. (QTIH)

Revance Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-19.49	-8.98	-6.1	-6.26	-5.42
Depreciation & Amortization	0.17	0.23	0.48	0.65	0.95
Other Amortization	-	-	-	0.04	0.01
Loss (Gain) From Sale of Assets	-	-	0	-	0.02
Stock-Based Compensation	0.34	3.99	0.71	0.9	2.51
Provision & Write-off of Bad Debts	-	0	-	-	-
Other Operating Activities	11.07	-3.88	0.6	0	-1.82
Change in Accounts Receivable	-2.3	-0.07	-0	0.01	-0.01
Change in Inventory	1.19	1.51	0.1	0.55	0.21
Change in Accounts Payable	0.22	-1.95	0.88	0.34	-0.11
Change in Unearned Revenue	-0.3	-0.3	0.35	-0.69	0.69
Change in Other Net Operating Assets	1.51	-0.57	0.33	0.59	0.26
Operating Cash Flow	-7.59	-10.03	-2.65	-3.86	-2.7
Capital Expenditures	-0.09	-0.09	-0.01	-0.02	-0.02
Sale of Property, Plant & Equipment	-	-	-	-	0
Investing Cash Flow	-0.09	-0.09	-0.01	-0.02	-0.02
Long-Term Debt Issued	-	10.53	1.51	1.99	3.7
Long-Term Debt Repaid	-	-2.08	-0.15	-0.13	-0.03
Net Debt Issued (Repaid)	4.11	8.45	1.36	1.86	3.67
Issuance of Common Stock	1	1.5	1.02	0.92	-
Other Financing Activities	-0.06	1.18	-	-	-
Financing Cash Flow	5.05	11.13	2.37	2.78	3.67
Net Cash Flow	-2.63	1.01	-0.29	-1.1	0.95
Free Cash Flow	-7.68	-10.12	-2.66	-3.88	-2.72
Free Cash Flow Margin	-121.66%	-207.46%	-6601.87%	-548.45%	-744.65%
Free Cash Flow Per Share	-0.33	-0.51	-0.28	-0.14	-0.10
Cash Interest Paid	0.39	0.54	0	0	0.01
Cash Income Tax Paid	-	-	-	0	0
Levered Free Cash Flow	-11.21	-6.75	-0.75	-1.94	-
Unlevered Free Cash Flow	-8.34	-3.94	-0.41	-1.69	-
Change in Net Working Capital	0.08	-3.24	-1.54	-0.4	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.